Search filters

List of works by Patrick Yeni

Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimen

scientific article published on 9 May 2014

Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen

scientific article published on November 13, 2011

Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study

scientific article published on 31 July 2016

Impact of Adding Enfuvirtide to the Predictive Value of the Darunavir Genotypic Resistance Score

scientific article published on 01 May 2011

Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study

scientific article published on 8 January 2017

Intensification of Antiretroviral Therapy through Addition of Enfuvirtide in Naive HIV-1-Infected Patients with Severe Immunosuppression Does Not Improve Immunological Response: Results of a Randomized Multicenter Trial (ANRS 130 Apollo)

scientific article published on November 19, 2012

Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients

scientific article published on 15 January 2009

Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome

scientific article published on 29 May 2012

Positive impact of HIV-1 gag cleavage site mutations on the virological response to darunavir boosted with ritonavir

scientific article published on 31 January 2011

Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients

scientific article published on 01 March 2012

Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial

scientific article

Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay

scientific article published on 19 June 2014